Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Impaired capacity for endogenous fibrinolysis in essential hypertension.

× No keyword cloud information.

14 in total

1. It is time to contend with the endothelial consequences of prehypertension.

Authors: G P Van Guilder
Journal: J Hum Hypertens Date: 2015-01-08 Impact factor: 3.012

2. The impaired fibrinolytic capacity in hypertension is unaffected by acute blood pressure lowering.

Authors: Wilhelm Ridderstråle; Ott Saluveer; Maria Carlström; Sverker Jern; Thórdís J Hrafnkelsdóttir
Journal: J Thromb Thrombolysis Date: 2011-11 Impact factor: 2.300

3. Histone deacetylase inhibitors stimulate tissue-type plasminogen activator production in vascular endothelial cells.

Authors: Pia Larsson; Niklas Bergh; Emma Lu; Erik Ulfhammer; Mia Magnusson; Karin Wåhlander; Lena Karlsson; Sverker Jern
Journal: J Thromb Thrombolysis Date: 2013-02 Impact factor: 2.300

4. Endogenous nitric oxide contributes to bradykinin-stimulated glucose uptake but attenuates vascular tissue-type plasminogen activator release.

Authors: Mias Pretorius; Nancy J Brown
Journal: J Pharmacol Exp Ther Date: 2009-10-19 Impact factor: 4.030

5. Effects of pulsatile minimal invasive extracorporeal circulation on fibrinolysis and organ protection in adult cardiac surgery-a prospective randomized trial.

Authors: Angelika Graßler; Robert Bauernschmitt; Irene Guthoff; Andreas Kunert; Markus Hoenicka; Günter Albrecht; Andreas Liebold
Journal: J Thorac Dis Date: 2019-06 Impact factor: 2.895

6. Role of histone acetylation in the stimulatory effect of valproic acid on vascular endothelial tissue-type plasminogen activator expression.

Authors: Pia Larsson; Erik Ulfhammer; Mia Magnusson; Niklas Bergh; Sebastian Lunke; Assam El-Osta; Robert L Medcalf; Per-Arne Svensson; Lena Karlsson; Sverker Jern
Journal: PLoS One Date: 2012-02-20 Impact factor: 3.240

Impaired capacity for endogenous fibrinolysis in essential hypertension.

1. It is time to contend with the endothelial consequences of prehypertension.

2. The impaired fibrinolytic capacity in hypertension is unaffected by acute blood pressure lowering.

3. Histone deacetylase inhibitors stimulate tissue-type plasminogen activator production in vascular endothelial cells.

4. Endogenous nitric oxide contributes to bradykinin-stimulated glucose uptake but attenuates vascular tissue-type plasminogen activator release.

5. Effects of pulsatile minimal invasive extracorporeal circulation on fibrinolysis and organ protection in adult cardiac surgery-a prospective randomized trial.

6. Role of histone acetylation in the stimulatory effect of valproic acid on vascular endothelial tissue-type plasminogen activator expression.

7. Profibrinolytic effect of the epigenetic modifier valproic acid in man.

8. Histone deacetylase inhibition enhances tissue plasminogen activator release capacity in atherosclerotic man.

9. Unsolved issues in the management of high blood pressure in acute ischemic stroke.

10. Histone deacetylase inhibitor treatment increases coronary t-PA release in a porcine ischemia model.